Zobrazeno 1 - 9
of 9
pro vyhledávání: '"W. George Case"'
Publikováno v:
Archives of general psychiatry. 47(10)
We compared the effect of abrupt discontinuation of therapeutic doses of short half-life and long half-life benzodiazepines in 57 benzodiazepine-dependent patients (daily use, greater than 1 year). Despite the use of a mean daily dose of 14.1 mg of d
Publikováno v:
Archives of general psychiatry. 47(10)
• We compared the effect on withdrawal severity and acute outcome of a 25% per week taper of short half-life vs long half-life benzodiazepines in 63 benzodiazepine-dependent patients. Patients unable to tolerate taper were permitted to slow the tap
Autor:
Jorge A. Pereira-Ogan, Charles C. Weise, Karl Rickels, Harold S. Feldman, W. George Case, Robert W. Downing
Publikováno v:
Journal of International Medical Research. 1:184-187
A multiple regression search analysis was conducted with 76 anxious outpatients treated in a 4 week clinical trial with either benzoctamine 60 mg/day or chlordiazepoxide 60 mg/day. Better response was predicted: For benzoctamine, in patients who are
Autor:
Arthur Schless, Irma Csanalosi, W. George Case, Karl Rickels, Charles C. Weise, Joshua Werblowsky
Publikováno v:
The American journal of psychiatry. 138(1)
In a double-blind, controlled study 158 outpatients with unipolar depression were treated for six weeks with amoxapine, imipramine, or placebo to assess the antidepressant effects of the new dibenzooxazepine compound, amoxapine. Forty-five amoxapine,
Autor:
W. George Case, Hack R. Chung, Jorge A. Pereira-Ogan, Robert W. Downing, Karl Rickels, Irma Csanalosi
Publikováno v:
The American journal of psychiatry. 131(1)
In a four-week study of 08 volunteer subjects with mixed symptoms of anxiety and depression, amitriptyline produced significantly more improvement than placebo. Significant differences were noted between the amitriptyline and placebo treatment groups
Publikováno v:
Archives of general psychiatry. 45(5)
Risk of withdrawal was investigated in a prospective, double-blind comparison of clorazepate dipotassium, a benzodiazepine with a long half-life, and the nonbenzodiazepine buspirone hydrochloride in the long-term treatment of anxious outpatients. Pat
Autor:
Richard J. Morris, Karl Rickels, Harris M Newman, Richard Mauriello, W. George Case, Hack R. Chung, Howard Rosenfeld
Publikováno v:
Clinical pharmacology and therapeutics. 40(3)
Sixty-three outpatients with chronic insomnia were treated for 3 weeks under double-blind conditions with either brotizolam (n = 29) at a dose of 0.25 mg or 0.5 mg or placebo (n = 34). A 3-day placebo period preceded and followed the double-blind tre
Autor:
W. George Case, Karl Rickels
Publikováno v:
Journal of Clinical Psychopharmacology. 2:428
Publikováno v:
JAMA: The Journal of the American Medical Association. 250:767
This double-blind study involved the continuous (six to 22 weeks) treatment of 180 chronically anxious outpatients with diazepam, 15 to 40 mg/day. Our findings indicate that a significant number of patients benefit from prolonged diazepam treatment a